Correlation Between Mersana Therapeutics and Tcr2 Therapeutics

Can any of the company-specific risk be diversified away by investing in both Mersana Therapeutics and Tcr2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mersana Therapeutics and Tcr2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mersana Therapeutics and Tcr2 Therapeutics, you can compare the effects of market volatilities on Mersana Therapeutics and Tcr2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mersana Therapeutics with a short position of Tcr2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mersana Therapeutics and Tcr2 Therapeutics.

Diversification Opportunities for Mersana Therapeutics and Tcr2 Therapeutics

0.39

Correlation Coefficient

Mersana Therapeutics  Tcr2 Therapeutics

Weak diversification

The 3 months correlation between Mersana and Tcr2 is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Mersana Therapeutics and Tcr2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tcr2 Therapeutics and Mersana Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mersana Therapeutics are associated (or correlated) with Tcr2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tcr2 Therapeutics has no effect on the direction of Mersana Therapeutics i.e., Mersana Therapeutics and Tcr2 Therapeutics go up and down completely randomly.

Pair Corralation between Mersana Therapeutics and Tcr2 Therapeutics

If you would invest  197.00  in Mersana Therapeutics on September 14, 2024 and sell it today you would earn a total of  33.00  from holding Mersana Therapeutics or generate 16.75% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	1.59%
Values	Daily Returns

Mersana Therapeutics  vs.  Tcr2 Therapeutics

Mersana Therapeutics

Risk-Adjusted Performance

5 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Mersana Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Mersana Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Tcr2 Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Tcr2 Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Tcr2 Therapeutics is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Mersana Therapeutics and Tcr2 Therapeutics

The main advantage of trading using opposite Mersana Therapeutics and Tcr2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mersana Therapeutics position performs unexpectedly, Tcr2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tcr2 Therapeutics will offset losses from the drop in Tcr2 Therapeutics' long position.

The idea behind Mersana Therapeutics and Tcr2 Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.